HETLIOZ (TASIMELTEON) CAPSULES Trademark

Trademark Overview

On Wednesday, February 5, 2014, a trademark application was filed for HETLIOZ (TASIMELTEON) CAPSULES with the United States Patent and Trademark Office. The USPTO has given the HETLIOZ (TASIMELTEON) CAPSULES trademark a serial number of 86185566. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, September 4, 2020. This trademark is owned by Vanda Pharmaceuticals Inc.. The HETLIOZ (TASIMELTEON) CAPSULES trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, containing tasimelteon, for use in the treatment of diseases and disorders of the central nervous system, diseases and disorders having an impact on the central nervous system, and diseases and disorders having a central nervous system manifestation
hetlioz (tasimelteon) capsules

General Information

Serial Number86185566
Word MarkHETLIOZ (TASIMELTEON) CAPSULES
Filing DateWednesday, February 5, 2014
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, September 4, 2020
Registration Number4756956
Registration DateTuesday, June 16, 2015
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 13, 2015

Trademark Statements

Description of MarkThe mark consists of "Hetlioz" on a first line, and "(tasimelteon) capsules" on a second line, with an arc of eleven solid circles of increasing size connecting the first and second lines of text.
Goods and ServicesPharmaceutical preparations, containing tasimelteon, for use in the treatment of diseases and disorders of the central nervous system, diseases and disorders having an impact on the central nervous system, and diseases and disorders having a central nervous system manifestation
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"TASIMELTEON CAPSULES"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 18, 2014
Primary Code005
First Use Anywhere DateTuesday, April 15, 2014
First Use In Commerce DateTuesday, April 15, 2014

Trademark Owner History

Party NameVanda Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWashington, DC 20037
Party NameVanda Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWashington, DC 20037
Party NameVanda Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWashington, DC 20037

Trademark Events

Event DateEvent Description
Wednesday, February 19, 2014NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, February 8, 2014NEW APPLICATION ENTERED
Tuesday, February 18, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 22, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, May 12, 2014ASSIGNED TO EXAMINER
Monday, May 19, 2014NON-FINAL ACTION WRITTEN
Monday, May 19, 2014NON-FINAL ACTION E-MAILED
Monday, May 19, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 5, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 5, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 6, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 6, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 14, 2014ASSIGNED TO LIE
Friday, December 5, 2014PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, September 9, 2014WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, October 15, 2014PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, November 18, 2014EXAMINERS AMENDMENT -WRITTEN
Tuesday, November 18, 2014EXAMINERS AMENDMENT E-MAILED
Tuesday, November 18, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 18, 2014EXAMINER'S AMENDMENT ENTERED
Tuesday, November 18, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 19, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, December 2, 2014WITHDRAWN FROM PUB - OG REVIEW QUERY
Friday, December 5, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 18, 2015TEAS STATEMENT OF USE RECEIVED
Wednesday, April 22, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 22, 2015STATEMENT OF USE PROCESSING COMPLETE
Tuesday, December 9, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, December 24, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 13, 2015PUBLISHED FOR OPPOSITION
Tuesday, January 13, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 10, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, March 18, 2015USE AMENDMENT FILED
Wednesday, May 13, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 16, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, June 16, 2020TEAS SECTION 8 & 15 RECEIVED
Tuesday, June 16, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, May 12, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, September 2, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, September 4, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, September 4, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sunday, June 16, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Related Keywords

capsules tasimelteon hetlioz central nervous system diseases disorders having impact manifestation preparations containing